Molecular mechanisms underlying mifepristone's agonistic action on ovarian cancer progression

BACKGROUND: Recent clinical trials on ovarian cancer with mifepristone (MF) have failed, despite in vitro findings on its strong progesterone (P4) antagonist function. METHODS: Ovarian cancer human and murine cell lines, cultured high-grade human primary epithelial ovarian cancer (HG-hOEC) cells and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EBioMedicine
Main Authors: Ponikwicka-Tyszko, Donata, Chrusciel, Marcin, Stelmaszewska, Joanna, Bernaczyk, Piotr, Chrusciel, Paulina, Sztachelska, Maria, Scheinin, Mika, Bidzinski, Mariusz, Szamatowicz, Jacek, Huhtaniemi, Ilpo T., Wolczynski, Slawomir, Rahman, Nafis A.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2019
Assuntos:
Research paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6796594/
https://ncbi.nlm.nih.gov/pubmed/31466918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2019.08.035
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados